Tag: drugs

GLP-1 labels carry pulmonary aspiration warning

Editor's Note The US Food and Drug Administration (FDA) has updated the labels of all treatments containing GLP-1 receptor agonists with a warning about warning about pulmonary aspiration during general anesthesia or deep sedation. Drugs and brand names listed in a November 8 report on the development from MedPage Today…

Read More

By: Matt Danford
November 12, 2024
Share

Research reveals racial disparity in postoperative pain management

Editor's Note Black patients are less likely to receive multimodal analgesia and more likely to be given additional oral opioids compared to white patients, according to research presented at the Anesthesiology 2024 annual meeting. According to an October 20 report on the retrospective study from the American Society of Anesthesiologists,…

Read More

By: Matt Danford
November 12, 2024
Share

Study: Single-syringe pump reduces OR propofol waste

Editor's Note Research published in the British Journal of Anaesthesia suggests that switching to a single syringe pump for both induction and maintenance of anesthesia could significantly cut propofol waste in operating rooms. EurekAlert! published the news October 29.  Propofol waste accounts for up to 45% of medication waste in…

Read More

By: Matt Danford
November 12, 2024
Share

Study: Beta-blockers could increase postoperative stroke risk

Editor's Note Research presented at the American Society of Anesthesiologists (ASA) annual meeting has found that beta-blocker use is associated with an increased risk of postoperative stroke, particularly among Black and Hispanic patients undergoing noncardiac surgeries, Medpage Today reported October 20. According to the article, the retrospective study analyzed the…

Read More

By: Matt Danford
November 7, 2024
Share

GOP-controlled Senate to prioritize drug pricing, health agency reform

Editor's Note Republicans secured a 51-seat majority in the US Senate after victories in Ohio and West Virginia, promising a power shift that will see GOP leaders shaping decisions on pressing issues like drug pricing, public health agency reform, and rural healthcare. On November 6, STAT published an overview of…

Read More

By: Matt Danford
November 6, 2024
Share

Study: NSAIDs reduce risk of postoperative delirium

Editor's Note A study presented at the 2024 American Society of Anesthesiologists annual meeting suggests that non-salicylate NSAIDs may significantly reduce the risk of postoperative delirium, a serious complication affecting up to 15% of surgical patients, Anesthesiology News reported October 20. Delirium is especially prevalent in older adults and those…

Read More

By: Matt Danford
October 25, 2024
Share

Study: Bariatric surgery more cost effective than GLP-1s

Editor's Note Combining newer weight loss drugs with bariatric surgery is the most cost-effective long-term strategy for treating obesity, according to research presented at the American College of Surgeons Clinical Congress 2024. Medical Xpress reported on the findings October 18. According to the article, researchers from Northwestern Medicine evaluated the…

Read More

By: Matt Danford
October 21, 2024
Share

Cardiovascular disease trends raise alarms on primary care

Editor's Note In a series of interviews with STAT, 11 cardiologists and other clinicians, including the FDA commissioner, said a crisis in primary care is dragging back progress in the nation’s cardiovascular health. Published October 15, the article begins with commentary on a stark warning from the American Heart Association…

Read More

By: Matt Danford
October 17, 2024
Share

Outpatient, ASC clinicians share perspectives on upcoming NOPAIN Act implementation

Editor's Note On October 14, Anesthesiology News published a monograph featuring clinical perspectives on how “those working in the trenches of postsurgical pain management” are preparing for the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act, which outlines new, separate Medicare reimbursement for certain non-opioid analgesics in outpatient and ambulatory…

Read More

By: Matt Danford
October 16, 2024
Share

Feds take action on Hurricane-wracked medical supply chain with wartime powers, drug compounding guidance

Editor's Note The Biden administration has invoked wartime powers to speed rebuilding of intravenous fluid (IV) manufacturing capacity, CBS News reported October 15, four days after the US Food and Drug Administration (FDA) took steps to combat drug shortages. Both efforts are in response to devastation wrought by Hurricane Helene,…

Read More

By: Matt Danford
October 16, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat